Achieving the goal of optimised renin system suppression: Predirical experience with a direct renin inhibitor
Aliskiren is the first orally available direct rennin inhibitor and is a highly potent and specific inhibitor of human renin. The high specificity for human renin has resulted in considerable challenges in utilising animal models in preclinical studies. Both marmoset and spontaneously hypertensive r...
Main Author: | Friedrich C Luft |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi - SAGE Publishing
2006-06-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | http://jra.sagepub.com/content/7/2_suppl/12.full.pdf |
Similar Items
-
Achieving the goal of optimised renin system suppression: preclinical experience with a direct renin inhibitor
by: Friedrich C Luft
Published: (2006-06-01) -
Measurement of bioactive renin concentration and renin activity in the presence of exogenous renin substrate: effect of the oral direct renin inhibitor aliskiren
by: Erik Frandsen, et al.
Published: (2008-03-01) -
Translating renin research to patient-related benefits
by: Friedrich C Luft
Published: (2008-03-01) -
New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Characteristics and Usefulness of the Direct Renin Inhibitor Aliskiren
by: Atsuhiro Ichihara, et al.
Published: (2010-01-01) -
Combination renin-angiotensin system blockade with the renin inhibitor aliskiren in hypertension
by: Timothy WR Doulton, et al.
Published: (2009-12-01)